All products are for Professional Use Only (PUO) — not intended for human or animal consumption

Back to Learn
Growth Hormone & PerformancePeptide

CJC-1295 no DAC (Mod GRF 1-29)

A short-acting GHRH analog (Modified GRF 1-29) without the Drug Affinity Complex, producing brief, pulsatile growth hormone release that more closely mimics natural GH secretion patterns.

Mechanism of Action

Modified GRF 1-29 (also called CJC-1295 without DAC or Mod GRF 1-29) is a synthetic analog of the first 29 amino acids of growth hormone-releasing hormone with four amino acid substitutions (Ala2, Gln8, Ala15, Leu27) that confer resistance to enzymatic degradation by dipeptidyl peptidase IV (DPP-IV). Without the DAC moiety, its half-life is approximately 30 minutes, producing a transient pulse of GH release from anterior pituitary somatotrophs. This short-acting profile better mimics the natural pulsatile pattern of GH secretion and is often combined with growth hormone-releasing peptides (GHRPs) for synergistic effects.

Research Applications

  • Studies have investigated pulsatile GH stimulation that mimics physiological secretion
  • Research has examined synergistic effects when combined with GHRPs like ipamorelin
  • Studies have explored body composition and recovery signaling pathways
  • Pharmacokinetic studies have characterized the short-acting release profile

Key Published Studies

1

Prakash A, Goa KL. Sermorelin: a review of its use in the diagnosis and treatment of children with idiopathic growth hormone deficiency. BioDrugs. 1999;12(2):139-157.

Key finding: Review of GHRH(1-29) analogs examining the pharmacology of pulsatile GHRH receptor activation for GH release, establishing the foundational receptor pharmacology shared by Mod GRF 1-29.

2

Wilton P, et al. Pharmacokinetics of growth hormone-releasing hormone(1-29)-NH2 and stimulation of growth hormone secretion in healthy subjects after intravenous or intranasal administration. Acta Paediatr Suppl. 1993;388:10-15.

Key finding: Measured GHRH(1-29)-NH2 pharmacokinetics and the growth hormone response it produced in healthy subjects across two routes of administration.

Research Use Only (RUO): This page summarizes published scientific research and is provided for educational and informational purposes only. It is not intended as medical advice, diagnosis, or treatment recommendations. The compound described carries a Research Use Only designation and is intended for laboratory research use only. It is not intended for human or animal consumption, or for use in the diagnosis, treatment, cure, or prevention of any disease. Consult qualified professionals before making any health-related decisions.

i2b Health Research Supply
RESEARCH USE ONLY

Age Verification Required

You must be 21 years of age or older to access this website. All products are intended for qualified researchers and laboratory use only.

By entering this site, you confirm that you are at least 21 years of age, that anything you acquire here is for research purposes, and that you agree to our Terms of Service and Research Use Only policy. Products are not intended for human or animal consumption.